1) Paeonia and Glycyrrhizina Decoction
芍甘合剂
1.
Determination of Paeoniflorin and Liquiritin in Paeonia and Glycyrrhizina Decoction by HPLC;
HPLC法测定芍甘合剂中芍药苷及甘草苷含量
2) Mushao composition
牡芍合剂
1.
Objective To study the effect of Mushao composition on β-EP and CCK-8 in the caudex dorsalis of rats with pain after fracture operation,and explore its mechanism.
目的观察牡芍合剂对骨折术后疼痛模型大鼠丘脑中β-内啡肽(β-EP)及八肽胆囊收缩素(CCK-8)的影响,探讨牡芍合剂的镇痛机理。
2.
Objective To study on the effect of Mushao Composition on β-EP and CCK-8 in the caudex dorsalis of rats with painless after the operation.
目的:研究牡芍合剂对骨折术后疼痛模型大鼠丘脑中β-内啡肽(β-EP)及八肽胆囊收缩素(CCK-8)的影响,探讨牡芍合剂的镇痛机理。
3) Chishaogancaochongji
赤芍甘草冲剂
1.
Protective effects of Chishaogancaochongji on chemical liver injury induced by D-galactosamine in mice;
赤芍甘草冲剂对D-半乳糖诱导肝损伤的保护作用
4) astragalus and paeoniae rubra misture
黄芪赤芍合剂
1.
Objective:To study the anti-oxidation capacity of astragalus and paeoniae rubra misture to mouse of immunological liver injury.
方法:采用卡介苗(BCG)和细菌脂多糖(LPS)诱导小鼠发生免疫性肝损伤,随机分为5组后,黄芪组、赤芍组、黄芪赤芍组分别给予黄芪提取物、赤芍提取物和黄芪赤芍合剂干预后,测定血清和肝组织中丙氨酸氨基转移酶(ALT)和丙二醛(MDA)的含量,超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-Px)的活性。
2.
[Objective] To investigate the inhibitive effect and possible mechanism of Astragalus and Paeoniae rubra misture on CCl4-ethanol-induced hepatic fibrosis rats.
方法以40%四氯化碳和5%乙醇制备大鼠肝纤维化动物模型,随机分为5组后,黄芪组、赤芍组、黄芪赤芍组分别给予黄芪提取物、赤芍提取物和黄芪赤芍合剂干预后,测定血清中丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、透明质酸酶(HA)、层黏蛋白(LN)水平;测定肝组织中超氧化物歧化酶(SOD)活性、丙二醛(MDA)含量;观察肝组织中LN的表达情况。
5) compound qishao mixture
复方芪芍合剂
1.
Quality control of compound qishao mixture;
复方芪芍合剂的质量控制
6) cWPROL
复方芍根合剂
1.
Bjective: The clinical therapeutic function of compound white peony root oral liquids (cWPROL) were studied.
目的:观察复方芍根合剂治疗急性放射性食管炎的临床疗效。
补充资料：甘氨酰-甘氨酰-甘氨酸
CAS: 556-33-2
分子式: C6H11N3O4
分子量: 189.17
熔点: 240-250℃
中文名称: 甘氨酰-甘氨酰-甘氨酸
英文名称: glycyl-glycyl-glycine；Glycine,N-(N-glycylglycyl)-；α-Diglycylglycin
分子式: C6H11N3O4
分子量: 189.17
熔点: 240-250℃
中文名称: 甘氨酰-甘氨酰-甘氨酸
英文名称: glycyl-glycyl-glycine；Glycine,N-(N-glycylglycyl)-；α-Diglycylglycin
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条